Skip to main content
Login
Contact
Subscribe
Search form
Search
The Borger News-Herald
Home
Forms
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Calendar
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Akers Biosciences
(NQ:
AKER
)
2.470
USD
UNCHANGED
Last Price
Updated: 7:52 PM EDT, Apr 16, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Akers Biosciences
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
17
18
Next >
AKER REMINDER: Pawar Law Reminds of Important August 13, 2018 Lead Plaintiff Deadline in Class Action - AKER
June 18, 2018
From
ACCESSWIRE
SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Akers Biosciences, Inc. (Nasdaq: AKER) To Conta
June 18, 2018
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New...
From
GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Akers Biosciences, Inc. - AKER
June 16, 2018
From
ACCESSWIRE
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
June 15, 2018
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc.
From
Business Wire News Releases
AKERS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akers Biosciences, Inc. To Contact The Firm
June 15, 2018
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER).
From
PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Akers Biosciences, Inc. - AKER
June 15, 2018
Pomerantz LLP is investigating claims on behalf of investors of Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER). Such investors are advised to contact Robert S. Willoughby at...
From
PR Newswire
SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Akers Biosciences, Inc. - AKER
June 14, 2018
From
ACCESSWIRE
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Akers Biosciences, Inc. (AKER) and Encourages Investors to Contact the Firm
June 14, 2018
Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the District of New Jersey on behalf of all persons or entities who purchased or...
From
GlobeNewswire News Releases
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Akers Biosciences, Inc. (AKER) & Lead Plaintiff Deadline - August 13, 2018
June 14, 2018
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER) and...
From
PR Newswire
Akers Class Action: Bernstein Liebhard LLP Announces That A Securities Class Action Lawsuit Has Been Filed Against Akers Biosciences, Inc. - AKER
June 13, 2018
Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of those who purchased or acquired the securities of Akers Biosciences, Inc. ("Akers" or the "Company")...
From
PR Newswire
Bragar Eagel & Squire, P.C. is Investigating Akers Biosciences, Inc. (AKER) on Behalf of Stockholders and Encourages Investors to Contact the Firm
June 13, 2018
Bragar Eagel & Squire, P.C. is Investigating Akers Biosciences, Inc. (AKER) on Behalf of Stockholders and Encourages Investors to Contact the Firm
From
Business Wire News Releases
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Akers Biosciences, Inc. – AKER
June 13, 2018
Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Akers Biosciences, Inc. (NASDAQ:AKER) from May 15, 2017...
From
GlobeNewswire News Releases
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Akers Biosciences, Inc. Investors (AKER)
June 13, 2018
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Akers Biosciences, Inc. Investors (AKER)
From
Business Wire News Releases
NEW INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
June 13, 2018
NEW INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc.
From
Business Wire News Releases
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Akers Biosciences, Inc. (AKER)
June 13, 2018
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER). Such investors...
From
PR Newswire
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Akers Biosciences, Inc. – AKER
June 13, 2018
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Akers Biosciences, Inc. (NASDAQ: AKER) resulting from...
From
Business Wire News Releases
Akers Shareholders: Bernstein Liebhard LLP Announces Investigation Of Akers Biosciences, Inc. - AKER
June 13, 2018
Bernstein Liebhard LLP is investigating potential securities fraud claims on behalf of shareholders of Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER). If you purchased Akers...
From
PR Newswire
Report: Developing Opportunities within Energy Fuels, Barclays, Herbalife LTD, China Lodging Group, Eco-Stim Energy Solutions, and Akers Biosciences — Future Expectations, Projections Moving into 2018
June 07, 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Energy Fuels Inc...
From
GlobeNewswire News Releases
58 Biggest Movers From Yesterday
May 31, 2018
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares surged 144.96 percent to close at $265.61 on Thursday in ...
Tags
MU
Movers From Yesterday
EXPR
From
Benzinga
Mid-Afternoon Market Update: J.Jill Climbs On Earnings Beat; Scpharmaceuticals Shares Fall
May 31, 2018
Toward the end of trading Thursday, the Dow traded down 0.91 percent to 24,442.32 while the NASDAQ declined 0.01 percent to 7,462.07. ...
Tags
Global
JILL
Benzinga
From
Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
May 31, 2018
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) jumped 124.8 percent to $243.725 in reaction to an encouraging Phase 2 ...
Tags
JILL
GM
Movers & Shakers
From
Benzinga
Mid-Day Market Update: Dow Down Over 250 Points; Madrigal Pharmaceuticals Shares Spike Higher
May 31, 2018
Midway through trading Thursday, the Dow traded down 1.07 percent to 24,404.07 while the NASDAQ declined 0.21 percent to 7,447.13. The ...
Tags
Markets
Intraday Update
Market News
From
Benzinga
Benzinga Pro's 5 Stocks To Watch Today
May 31, 2018
Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a ...
Tags
Pre/Market Outlook
News
AKER
From
Benzinga
Benzinga's Daily Biotech Pulse: Clinical Hold For Crispr, Gilead Study Meets Endpoint, Akers Gets Grace Time
May 31, 2018
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week ...
Tags
Top Stories
NTRP
GHDX
From
Benzinga
Akers Biosciences Granted 180-Day Extension by Nasdaq to Meet Minimum Bid Price Requirement
May 30, 2018
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces that, on May 30, 2018, the Listing Qualifications...
From
GlobeNewswire News Releases
42 Biggest Movers From Yesterday
May 29, 2018
Gainers Acorn International, Inc. (NYSE: ATV) shares jumped 32.89 percent to close at $37.70 on Tuesday. Acorn shares ...
Tags
RRTS
EDUC
TTOO
From
Benzinga
Mid-Afternoon Market Update: Crude Oil Down 2.5%; American Woodmark Shares Spike Higher
May 29, 2018
Toward the end of trading Tuesday, the Dow traded down 1.52 percent to 24,376.02 while the NASDAQ declined 0.54 percent to 7,393.52. The ...
Tags
Mid/Afternoon Market Update
RRTS
MYSZ
From
Benzinga
37 Stocks Moving In Tuesday's Mid-Day Session
May 29, 2018
Gainers Axovant Sciences Ltd. (NASDAQ: AXON) shares rose 23.7 percent to $1.49. Axovant announced strengthening of management ...
Tags
AEZS
SVRA
GCO
From
Benzinga
Mid-Day Market Update: Dow Falls Over 400 Points; T2 Biosystems Shares Plunge
May 29, 2018
Midway through trading Tuesday, the Dow traded down 1.67 percent to 24,340.59 while the NASDAQ declined 0.73 percent to 7,379.71. The ...
Tags
BAH
Global
AKER
From
Benzinga
Akers Biosciences Withdraws FDA 510(k) Submission for PIFA Chlamydia Rapid Assay Pending Further Evaluation
May 29, 2018
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces that, upon a recommendation from the US Food and...
From
GlobeNewswire News Releases
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
17
18
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.